{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:12:22Z","timestamp":1782983542510,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SRG\/2019\/000398"],"award-info":[{"award-number":["SRG\/2019\/000398"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020217","name":"Sanjay Gandhi Post Graduate Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bbadis.2023.166662","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T02:11:10Z","timestamp":1675649470000},"page":"166662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice"],"prefix":"10.1016","volume":"1869","author":[{"given":"Sangam","family":"Rajak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandana","family":"Chakravarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baby","family":"Anjum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhulika","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit A.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166662_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.bbadis.2023.166662_bb0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","article-title":"Fatty liver disease: diagnosis and stratification","volume":"73","author":"Saiman","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbadis.2023.166662_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.eprac.2021.12.010","article-title":"Fatty liver through the ages: nonalcoholic steatohepatitis","volume":"28","author":"Younossi","year":"2022","journal-title":"Endocr.Pract."},{"key":"10.1016\/j.bbadis.2023.166662_bb0020","first-page":"42","article-title":"Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"5","author":"Raza","year":"2019","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.bbadis.2023.166662_bb0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbadis.2023.166662_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbadis.2023.166662_bb0035","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2023.166662_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg.2018.4","article-title":"Integrative omics for health and disease","volume":"19","author":"Karczewski","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbadis.2023.166662_bb0045","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/138920112799857558","article-title":"Non-alcoholic steatohepatitis: new insights from OMICS studies","volume":"13","author":"Martel","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbadis.2023.166662_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10204673","article-title":"Defining NASH from a multi-omics systems biology perspective","volume":"10","author":"Niu","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbadis.2023.166662_bb0055","article-title":"The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease","volume":"111s","author":"Perakakis","year":"2020","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbadis.2023.166662_bb0060","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166662_bb0065","doi-asserted-by":"crossref","first-page":"F796","DOI":"10.1152\/ajprenal.00237.2002","article-title":"CFTR null mutation altered cAMP-sensitive and swelling-activated Cl- currents in primary cultures of mouse nephron","volume":"284","author":"Barriere","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbadis.2023.166662_bb0070","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajpath.2012.06.017","article-title":"CFTR is involved in the fine tuning of intracellular redox status: physiological implications in cystic fibrosis","volume":"181","author":"Duranton","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2023.166662_bb0075","doi-asserted-by":"crossref","first-page":"F435","DOI":"10.1152\/ajprenal.00286.2009","article-title":"CFTR mediates apoptotic volume decrease and cell death by controlling glutathione efflux and ROS production in cultured mice proximal tubules","volume":"298","author":"l'Hoste","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbadis.2023.166662_bb0080","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2023.166662_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.355","article-title":"Role of CFTR in oxidative stress and suicidal death of renal cells during cisplatin-induced nephrotoxicity","volume":"4","author":"Rubera","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2023.166662_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2023.166662_bb0095","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2023.166662_bb0100","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2023.166662_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166319","article-title":"Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse","volume":"1868","author":"Rajak","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2023.166662_bb0110","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2023.166662_bb0115","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI0216112","article-title":"Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion","volume":"110","author":"Ma","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2023.166662_bb0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20080029","article-title":"Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis","volume":"413","author":"Caci","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2023.166662_bb0125","doi-asserted-by":"crossref","first-page":"24437","DOI":"10.18632\/oncotarget.15510","article-title":"High CFTR expression in Philadelphia chromosome-positive acute leukemia protects and maintains continuous activation of BCR-ABL and related signaling pathways in combination with PP2A","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2023.166662_bb0130","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/emboj\/cdg194","article-title":"CFTR directly mediates nucleotide-regulated glutathione flux","volume":"22","author":"Kogan","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2023.166662_bb0135","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21635","article-title":"Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure","volume":"45","author":"Chen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2023.166662_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12876-017-0652-3","article-title":"Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study","volume":"17","author":"Honda","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbadis.2023.166662_bb0145","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/hep.28817","article-title":"The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity","volume":"64","author":"Fiorotto","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2023.166662_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41419-017-0216-z","article-title":"Homocysteine activates autophagy by inhibition of CFTR expression via interaction between DNA methylation and H3K27me3 in mouse liver","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:13:43Z","timestamp":1760418823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0925443923000285"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166662","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166662"}}